Detection of presymptomatic cerebral amyloid angiopathy, CAA, using diffusion MRI analysis of cortical grey matter in hereditary mutation carriers
Steven A Chance, Ian Hardingham, Michele Valotti, Sanneke van Rooden, Jeroen van der Grond · 2025
Read Detection of presymptomatic cerebral amyloid angiopathy, CAA, using diffusion MRI analysis of cortical grey matter in hereditary mutation carriers by Steven A Chance, Ian Hardingham, Michele Valotti, Sanneke van Rooden, Jeroen van der Grond (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712419.txt.
Description
Steven Chance and co-authors test whether diffusion MRI of cortical grey matter can spot cerebral amyloid angiopathy before symptoms start. Carriers of a Dutch hereditary mutation develop this vessel disease early, and white matter diffusion scans missed changes in symptom-free carriers in past work. Their cortical disarray measure reads the tiny column structure of the cortex from diffusion signals.
Data covered twelve carriers with symptoms, eleven without, and twenty-four non-carrier controls, all scanned once. One diffusion measure was higher in carriers across the whole cortex, driven by the group with symptoms. In set regions, some measures split carriers from controls even without symptoms, a step toward early detection of the disease.
Catalog record
| CREATOR | Steven A Chance, Ian Hardingham, Michele Valotti, Sanneke van Rooden, Jeroen van der Grond |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |